TLDR Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.
Cronkhite-Canada syndrome (CCS) is a rare, nonheritable condition marked by gastrointestinal polyposis, diarrhea, and ectodermal changes such as hair loss and nail atrophy. This report discusses a 72-year-old woman with CCS, whose symptoms improved significantly with prednisone and nutritional support. The literature review highlights the varied clinical manifestations, including alopecia, and classifies CCS into five types based on initial symptoms. Despite treatment options like corticosteroids, the prognosis remains poor, with a 5-year mortality rate of up to 55%. A study of 383 patients showed that 91 had concurrent tumors, stressing the importance of long-term endoscopic follow-up. While steroids effectively control inflammation, the rarity of CCS limits the generalizability of findings, emphasizing the need for early diagnosis and sustained treatment to prevent complications.
19 citations,
August 2020 in “Gastroenterology report” There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.
16 citations,
May 2013 in “Australasian Journal of Dermatology” Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.
[object Object]
1 citations,
March 2022 in “Frontiers in Medicine” Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.
[object Object] October 2019 in “Journal of Evolution of Medical and Dental Sciences” A 56-year-old man was diagnosed with Cronkhite-Canada Syndrome after showing symptoms like diarrhea, weight loss, and skin changes.
6 citations,
November 2018 in “Case reports in nephrology and dialysis” Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.
August 2023 in “Gastroenterology” A 78-year-old man with Cronkhite-Canada syndrome improved significantly after treatment and remains symptom-free.
16 citations,
May 2013 in “Australasian Journal of Dermatology” Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.